Pikarsky et al. and Greten et al. reported that the classical, IKK-dependent NF-κB-activation pathway is a crucial mediator of tumor progression (Greten et al., 2004; Pikarsky et al., 2004). The gene discussed is NFKB1; the disease is neoplasm.